Literature DB >> 12651817

Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis.

Eric Ballot1, Arnaud Bruneel, Valérie Labas, Catherine Johanet.   

Abstract

BACKGROUND: Anti-soluble liver antigen (SLA) autoantibodies are specific for autoimmune hepatitis type 1 and are the only immunologic marker found in 15-20% of hepatitis cases previously considered cryptogenic. Anti-SLA antibodies react with the 100 000g supernatant from rat liver homogenate, but the molecular targets remain controversial.
METHODS: We characterized anti-SLA targets by one- and two-dimensional immunoblotting analysis. The recognized proteins were identified by peptide mass fingerprint analysis after matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.
RESULTS: Three proteins of 35 kDa and pI 6.0, 50 kDa and pI between 6.0 and 6.5, and 58 kDa and pI between 6.5 and 7.0 were stained more intensely by anti-SLA positive-sera than by control sera. After in-gel tryptic digestion, MALDI-TOF analysis of the generated peptides enabled the clear identification of N-hydroxyarylamine sulfotransferase, isoforms of alpha-enolase, and isoforms of catalase.
CONCLUSIONS: Possible antigens for anti-SLA antibodies include a sulfotransferase, alpha-enolase(s), and catalase(s). Two-dimensional electrophoresis combined with mass spectrometry offers a versatile tool to identify molecular targets of autoantibodies and thus to improve diagnostic tools and the understanding of the immune process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651817     DOI: 10.1373/49.4.634

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.

Authors:  Jason M God; Dan Zhao; Christine A Cameron; Shereen Amria; Jennifer R Bethard; Azizul Haque
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

2.  Absence of keratin 8 or 18 promotes antimitochondrial autoantibody formation in aging male mice.

Authors:  Diana M Toivola; Aida Habtezion; Julia O Misiorek; Linxing Zhang; Joel H Nyström; Orr Sharpe; William H Robinson; Raymond Kwan; M Bishr Omary
Journal:  FASEB J       Date:  2015-09-23       Impact factor: 5.191

3.  Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome.

Authors:  Theodor Chitlaru; Orit Gat; Haim Grosfeld; Itzhak Inbar; Yael Gozlan; Avigdor Shafferman
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

Review 4.  Autoimmune liver serology: current diagnostic and clinical challenges.

Authors:  Dimitrios-P Bogdanos; Pietro Invernizzi; Ian-R Mackay; Diego Vergani
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

5.  Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis.

Authors:  Dimitrios-Petrou Bogdanos; Daniele Gilbert; Ilaria Bianchi; Simona Leoni; Ragai R Mitry; Yun Ma; Giorgina Mieli-Vergani; Diego Vergani
Journal:  J Autoimmune Dis       Date:  2004-11-19

6.  An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies.

Authors:  Virginie Dutoit-Lefèvre; Sylvain Dubucquoi; David Launay; Vincent Sobanski; Patricia Dussart; Philippe Chafey; Cédric Broussard; Sophie Duban-Deweer; Patrick Vermersch; Lionel Prin; Didier Lefranc
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 7.  α-Enolase, a multifunctional protein: its role on pathophysiological situations.

Authors:  Angels Díaz-Ramos; Anna Roig-Borrellas; Ana García-Melero; Roser López-Alemany
Journal:  J Biomed Biotechnol       Date:  2012-10-14

8.  Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients.

Authors:  Hongbin Li; Guoshun Li; Xinyu Zhao; Yongkang Wu; Wen Ma; Yuling Liu; Fengming Gong; Shufang Liang
Journal:  J Transl Med       Date:  2013-06-13       Impact factor: 5.531

9.  Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma.

Authors:  Mohammad Zahid Mustafa; Viet Hung Nguyen; François Le Naour; Eleonora De Martin; Elvire Beleoken; Catherine Guettier; Catherine Johanet; Didier Samuel; Jean-Charles Duclos-Vallee; Eric Ballot
Journal:  J Transl Med       Date:  2016-01-16       Impact factor: 5.531

10.  Analysis of Differentially Expressed Proteins Involved in Autoimmune Cirrhosis and Normal Serum by iTRAQ Proteomics.

Authors:  Zheng Minghui; Hu Kunhua; Bao Yunwen; Lu Hongmei; Li Jing; Wu Shaowen; Sun Longqiaozi; Duan Chaohui
Journal:  Proteomics Clin Appl       Date:  2018-08-09       Impact factor: 3.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.